Soon, simple jab could beat major diseases
London: A simple jab, which could tackle a host of devastating diseases, is a step closer to reality.
Scientists have pinpointed a protein responsible for the growth of "bad" blood vessels in the body.
A team from the Institute of Ophthalmology, at University College London, is already working on creating a drug which can block the protein, the New York Daily News reported.
The discovery has massive implications for treating cancer, the eye condition age-related macular degeneration and rheumatoid arthritis.
Clinical trials could start in 18 months, possibly leading to a treatment by injection within five to seven years.
The study`s lead author, professor John Greenwood, said that they have been able to show they can reduce this blood vessel growth by blocking a protein using an antibody drug.
He said that they hope it will help those who are not responding to current treatments which are also targeting blood vessel growth.
The team found the protein called LRG1 in tests on mice with a type of eye disease, but believe the results are equally applicable to humans.
The study was published in the journal Nature.
More from India
More from World
More from Sports
More from Entertaiment
- Indian- Americans launch online petition to declare Pakistan 'sponsor of terrorism'
- Panel discussion over PM Modi's willingness to engage in direct dialogue with Pak
- EU warns Pakistan of political and economic sanctions over atrocities in Baloch
- Should Pakistani artists be restricted from working in India?
- PM Modi slams Pakistan govt during his speech in Kozhikode
- SHOCKING VIDEO: This man was trying to take selfie with python - You won't believe what happened next!
- Call up this number and get Reliance Jio's SIM for sure
- WATCH: Ravichandran Ashwin's magic ball that bamboozled Kane Williamson on Day 3
- If you have guts, send your suicide bombers to Pakistan: Samajwadi Party to MNS' Raj Thackeray
- Govt calls meet on Indus Water Treaty; Water Resources Ministry, MEA to brief PM Modi